Search Results 821-830 of 21420 for anti-TNF drugs

  1. Epirubicin (Intravenous Route) Precautions - Mayo Clinic

    Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 3 months after the last dose.

  2. Peginterferon Alfa-2b (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Thiethylperazine (Oral Route, Intramuscular Route, Rectal Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Torecan. Descriptions. Thiethylperazine is a phenothiazine ...

  4. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

    A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.

  5. Carboplatin (Intravenous Route) Side Effects - Mayo Clinic

    Less common. Constipation or diarrhea; loss of appetite. This medicine may cause a temporary loss of hair in some people. After treatment with carboplatin has ...

  6. Kidney transplant - Mayo Clinic

    Anti-rejection medication side effects. After a kidney transplant, you'll take medications to help prevent your body from rejecting the donor kidney. These ...

  7. Fenofibrate (Oral Route) Precautions - Mayo Clinic

    Serious skin reactions, including Steven-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS) can ...

  8. Entacapone (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Comtan. Descriptions. Entacapone is used ...

  9. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... [TNFα] antagonists, ustekinumab, vedolizumab) and ... Adalimumab 40 mg qwk > 7.5mg/ml Certolizumab 400 mg ...

  10. Nuclear Medicine Therapy - Clinical trials

    The purpose of this study is to compare capecitabine and temozolomide to lutetium Lu 177 dotatate for the treatment of pancreatic neuroendocrine tumors that ...